Aventis Pharma net up 16% at Rs 55 cr

Aventis Pharma today reported a 15.85% increase in its net profit to Rs 54.8 crore for the third quarter ended September 2011 boosted by overall good sales.

The company had posted a net profit of Rs 47.3 crore for the quarter ended September 2010 Aventis Pharma said in a filing to BSE.

Net sales of the company stood at Rs 312.7 crore for the quarter ended September 30,2011 as against Rs 275.6 crore for the corresponding period previous fiscal.

During the quarter the company entered into a definitive agreement with Universal Medicare Private Ltd to acquire marketing and distribution business of branded neutraceutical formulations in India, Aventis Pharma said.

Shares of Aventis Pharma today closed at Rs 2,350 per share, up 0.05% from their previous close.